
David Rosenthal, DO, PhD, medical director for the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwall Health, explains why condom use is still recommended for HIV patients on antiretroviral therapy.


David Rosenthal, DO, PhD, medical director for the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwall Health, explains why condom use is still recommended for HIV patients on antiretroviral therapy.

David Rosenthal, DO, PhD, medical director at the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwell Health, reflects on a JAMA study, which states that use of antiretroviral therapy reduced the risk of HIV transmission during condomless sex.

Tanner White, a marine who has been diagnosed with HIV is making strides in fighting HIV-associated stigma by providing the public with education on the virus through the creation of his nonprofit organization called, “A Positive Tomorrow.”

The World Health Organization (WHO) has just released new guidelines for treating chlamydia, gonorrhea, and syphilis; three of the most common sexually transmitted infections (STIs) due to the increased threat of antibiotic resistance.

In the United States, Shigellosis causes approximately 500,000 illnesses annually and resistance to drugs to treat the infection, such as ciprofloxacin, ceftriaxone, and azithromycin, is emerging.

Researchers at the Vanderbilt University School of Medicine have found that HIV-infected adults with depression are at a higher risk for cardiovascular disease and are more likely to experience heart attacks.

Researchers at the Seattle Children’s Research Institute found a strain of herpes, human herpes 7, in the nervous system of an animal model.

Researchers from the Copenhagen University Hospital of Denmark find that individuals who are hospitalized with infections have an increased risk of suicide ideation and death; individuals infected with hepatitis and HIV or AIDS have the highest risk of suicide-related death.

A new study finds that a balance of mutations, ones that impair the immune system’s ability to detect the HIV virus, and ones that impair the virus’s ability to replicate, will influence the speed of disease progression.

News has emerged of a case in Maryland involving the identification of Zika infection in a woman who had sexual contact with a man who did not know he was sick because he was asymptomatic.

By using a fruit fly model of human papillomavirus (HPV) induced human cancer, a team of researchers from the University of Missouri hope to better understand the mechanism that allows HPV to cause cancer as well as identify therapies that can potentially treat HPV-induced cancers.

A UNC bioethicist is leading the PHASES Project, funded by a grant of over $3 million from the National Institutes of Health, in an effort to address the need for effective HIV prevention and treatment options for pregnant women worldwide.

An essential component of HIV that explains how the virus infects other cells and remains undetected by the immune system has been discovered by researchers at the MRC Laboratory of Molecular Biology in Cambridge and the University of London.

A new study conducted by researchers at John Hopkins Medicine has found that most of the proviruses in the latent HIV reservoir are defective but the current methods used to measure size of reservoirs, PCR and QVOA, are not precise in their measurements in that their results often count proviruses with and without defects.

A new study found that girls between 9 and 14 years of age who received a two-dose HPV-16/18 AS04-adjuvanted vaccine over a 6 or 12-month period of time are just as protected from HPV as girls between 15 and 25 years of age who received a three-dose vaccine over the course of 6 months.

Researchers have found that although HIV makes individuals more susceptible to acquire tuberculosis, it is not the cause of the spread of multidrug-resistant tuberculosis.

Although several ambitious initiatives intended to put an end to the AIDS epidemic have been developed and implemented, this laudable goal will be difficult to achieve without substantial and wide-scale changes in HIV prevention strategies.

Chlamydia has posed a healthcare challenge for clinicians due to the serious complications associated with it.

After failed requests for funding and warnings of the inevitable, the Florida Department of Health is investigating what could be the first cases of active Zika Transmission in the United States.

Recently, there have been several breakthroughs in the fight against HIV, including trials that would test an HIV vaccine targeting a specific subtype of the virus, and several prevention methods that would reduce the risk of infection transmission.

Recent studies show that women are at higher risk of contracting HIV; however, measures can be taken to prevent infection, as well as the transmission of HIV from mother to child.

Researchers from the United Kingdom have demonstrated how whole genome sequencing technology can be used to track the spread of infection in Neisseria gonorrhea—an important finding given that the number of drug-resistant strains of the sexually transmitted infection (STI) has reportedly been increasing.

Groundbreaking research has uncovered several possibilities to potentially cure HIV in patients receiving antiretroviral therapy (ART), while a new drug prohibits the virus from maturing, preventing viral infection of new cells.

On the heels of new data suggesting the Zika epidemic will last for another 3 years, a new case reveals there may be a new mode of zika transmission.

A new technological approach to genome editing that can clear latent and productive herpesvirus infections from human cells in vitro could eventually lead to a potent prophylactic.